Qualigen Therapeutics adds Braeden Lichti to board; Robert Lim named audit chair; Korenberg resigns

AIxCrypto Holdings, Inc.

Matt Korenberg resigned director and audit chair Oct 3, 2024; no disagreement cited.
Braeden Lichti appointed independent director Oct 8, 2024; founder of BWL Investments and NorthStrive.
Robert Lim appointed as audit committee chairperson effective Oct 8, 2024.
Director agreement includes $5,000 monthly base fee, equity eligibility, and standard indemnification.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Braeden Lichti

Independent Director

AIXC · AIxCrypto Holdings, Inc.

Effective: 2024-10-08
Filed: October 9, 2024, 7:59 PM ET

On October 8, 2024, the Board of Directors (the “Board”) appointed Braeden Lichti as an independent member of the Board, effective immediately, and approved the Director Agreement, attached hereto as Exhibit 10.1.

Departed

Matt Korenberg

Independent Director and Chairman of Audit Committee

AIXC · AIxCrypto Holdings, Inc.

Effective: 2024-10-03
Filed: October 9, 2024, 7:59 PM ET

On October 3, 2024, Mr. Matt Korenberg, independent member and chairman of the audit committee of the board of directors (the “Board”) of Qualigen Therapeutics, Inc. (the “Company”), tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Braeden Lichti was appointed as Independent Director at AIxCrypto Holdings, Inc..

Action: appointed
Role: Independent Director

Exact text from the filing

On October 8, 2024, the Board of Directors (the “Board”) appointed Braeden Lichti as an independent member of the Board, effective immediately, and approved the Director Agreement, attached hereto as Exhibit 10.1.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Matt Korenberg resigned as Independent Director and Chairman of Audit Committee at AIxCrypto Holdings, Inc..

Action: resigned
Role: Independent Director and Chairman of Audit Committee

Exact text from the filing

On October 3, 2024, Mr. Matt Korenberg, independent member and chairman of the audit committee of the board of directors (the “Board”) of Qualigen Therapeutics, Inc. (the “Company”), tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.

View on SEC.gov

AIxCrypto Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-040599

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.